Skip to main content
Clinical Trials/NCT03500536
NCT03500536CompletedNot Applicable

Implementing an Innovative Suite of Mobile Applications for Depression and Anxiety

Actualize Therapy2 sites in 1 country146 target enrollmentStarted: July 18, 2018Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
146
Locations
2
Primary Endpoint
Symptoms of depression

Study Overview

Brief Summary

The clinical study is meant to optimize the mobile intervention, to develop a robust implementation plan for the mobile intervention within primary care, and to conduct an effectiveness trial, randomizing 128 participants in order to understand effect on severity of depression and anxiety symptoms, cost-effectiveness, and usability of mobile apps.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Supportive Care
Masking
Triple (Participant, Care Provider, Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Positive screen on PHQ-9

Exclusion Criteria

  • Does not own or use a mobile smart phone

Arms & Interventions

Waitlist Control

No Intervention

8 weeks of treatment as usual followed by 8 weeks of IntelliCare treatment.

Experimental

Experimental

8 weeks of IntelliCare treatment followed by 8 weeks of treatment as usual.

Intervention: IntelliCare (Behavioral)

Outcomes

Primary Outcomes

Symptoms of depression

Time Frame: 8 weeks

Using the PHQ-9 screener

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor
Actualize Therapy
Sponsor Class
Industry
Responsible Party
Principal Investigator
Principal Investigator

Pauli Lieponis

Interim Principal Investigator

Actualize Therapy

Study Sites (2)

Loading locations...

Similar Trials